Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $111.48 USD
Change Today +0.18 / 0.16%
Volume 33.0K
ICUI On Other Exchanges
Symbol
Exchange
Berlin
As of 11:51 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (ICUI) Snapshot

Open
$111.51
Previous Close
$111.30
Day High
$112.15
Day Low
$111.44
52 Week High
08/18/15 - $124.69
52 Week Low
09/23/14 - $60.92
Market Cap
1.8B
Average Volume 10 Days
181.1K
EPS TTM
$2.95
Shares Outstanding
15.8M
EX-Date
--
P/E TM
37.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for ICU MEDICAL INC (ICUI)

icu medical inc (ICUI) Related Businessweek News

No Related Businessweek News Found

icu medical inc (ICUI) Details

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics. The company’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave clear, anti-microbial MicroClave, neutrons, NanoClave, and Clave; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products used to monitor signs, as well as physiological functions of organ systems. The company’s critical care products comprises hemodynamic monitoring systems, including Transpac disposable pressure transducers, Safeset closed needlefree blood conservation systems, and custom monitoring systems; sensor, pulmonary artery thermodilution, central venous oximetry, and multi-lumen central venous catheters; custom angiography and interventional radiology kits; and Lopez enteral valves. In addition, it offers a line of oncology products that are used to prepare and deliver hazardous medications used in chemotherapy, such as ChemoLock and ChemoClave closed system transfer device and components, and Diana hazardous drug compounding system. The company sells its products to medical product manufacturers, independent distributors, and directly to end users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

2,280 Employees
Last Reported Date: 02/20/15
Founded in 1984

icu medical inc (ICUI) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $574.2K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $395.2K
Vice President of Operations
Total Annual Compensation: $390.5K
Vice President and General Manager of Critica...
Total Annual Compensation: $333.6K
Vice President and General Manager of Infusio...
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2014.

icu medical inc (ICUI) Key Developments

ICU Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Full Year 2015

ICU Medical, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $83,662,000 against $78,555,000 a year ago. Total revenue was $83,781,000 against $78,677,000 a year ago. Income from operations was $20,321,000 against $8,698,000 a year ago. Income before income taxes was $20,561,000 against $8,905,000 a year ago. Net income was $13,570,000 against $5,878,000 a year ago. Diluted earnings per share were $0.83 against $0.38 a year ago. Adjusted EBITDA was $28,092,000 against $16,292,000 a year ago. Adjusted diluted earnings per share were $0.97 against $0.51 a year ago. For the six months, the company reported net sales of $164,985,000 against $151,668,000 a year ago. Total revenue was $165,265,000 against $151,907,000 a year ago. Income from operations was $31,294,000 against $18,575,000 a year ago. Income before income taxes was $32,060,000 against $18,992,000 a year ago. Net income was $23,256,000 against $12,535,000 a year ago. Diluted earnings per share were $1.43 against $0.81 a year ago. Net cash provided by operating activities was $25,750,000 against $29,275,000 a year ago. Purchases of property and equipment was $5,005,000 against $12,729,000 a year ago. Intangible asset additions was $440,000 against $377,000 a year ago. Adjusted EBITDA was $54,092,000 against $33,117,000 a year ago. Adjusted diluted earnings per share were $2.00 against $1.06 a year ago. For the year 2015, the company expects GAAP net income to be in the range from $43,022,000 to $46,289,000, adjusted EBITDA to be in the range from $100,090,000 to $105,040,000, GAAP diluted earnings per share to be in the range from $2.63 to $2.83, Adjusted diluted earnings per share to be in the range from $3.49 to $3.69.

ICU Medical, Inc., Q2 2015 Earnings Call, Aug 10, 2015

ICU Medical, Inc., Q2 2015 Earnings Call, Aug 10, 2015

ICU Medical, Inc. to Report Q2, 2015 Results on Aug 10, 2015

ICU Medical, Inc. announced that they will report Q2, 2015 results at 4:00 PM, US Eastern Standard Time on Aug 10, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICUI:US $111.48 USD +0.18

ICUI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $64.66 USD +0.51
Masimo Corp $40.52 USD +0.36
NxStage Medical Inc $16.43 USD -0.52
Orthofix International NV $37.17 USD -0.06
Wright Medical Group Inc $25.64 USD +0.50
View Industry Companies
 

Industry Analysis

ICUI

Industry Average

Valuation ICUI Industry Range
Price/Earnings 47.7x
Price/Sales 5.4x
Price/Book 3.2x
Price/Cash Flow 47.0x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit www.icumed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.